Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study

Abstract Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is the preferred treatment for acute ischemic stroke (AIS). Nevertheless, only approximately half of patients undergoing IVT experience positive outcomes. The objective of the study was to examine the clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Yayun Xu, Haixing Feng, Zhengzheng Huang, Yanlei Li, Feng Chi, Lijie Ren
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Thrombosis Journal
Subjects:
Online Access:https://doi.org/10.1186/s12959-025-00704-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850039986026446848
author Yayun Xu
Haixing Feng
Zhengzheng Huang
Yanlei Li
Feng Chi
Lijie Ren
author_facet Yayun Xu
Haixing Feng
Zhengzheng Huang
Yanlei Li
Feng Chi
Lijie Ren
author_sort Yayun Xu
collection DOAJ
description Abstract Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is the preferred treatment for acute ischemic stroke (AIS). Nevertheless, only approximately half of patients undergoing IVT experience positive outcomes. The objective of the study was to examine the clinical characteristics of patients with AIS and identify predictors for unfavorable clinical outcomes at 3 months after IVT. This retrospective cohort study comprised 3805 consecutive patients diagnosed with AIS who received IVT. Patients categorized as having a poor outcome were those with a modified Rankin scale score (mRS) of 3–6, while those categorized as having a good outcome had a score of 0–2. Clinical profiles and laboratory examinations were compared among patients with differing outcomes. A logistic regression model was utilized to investigate potential factors correlated with unfavorable outcomes. Of the 3805 patients included in the study, 3176 (83.5%) were found to have a good outcome, while 629 (16.5%) experienced an poor outcome following IVT. Advancing age (OR = 1.037, P < 0.001) and higher baseline National Institutes of Health Stroke Scale (NIHSS) scores (OR = 1.156, P < 0.001) were significant independent predictors of a poor outcome. The area under curve (AUC) values for age, NIHSS score, and the combined effect of age and NIHSS score in predicting a poor response were 0.644, 0.761, and 0.777, respectively. Our research indicates that advancing age and higher baseline NIHSS score may serve as prognostic indicators for predicting early unfavorable outcomes following IVT in patients with AIS.
format Article
id doaj-art-39dfa030419047e89bd8633a4d0a9fd5
institution DOAJ
issn 1477-9560
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series Thrombosis Journal
spelling doaj-art-39dfa030419047e89bd8633a4d0a9fd52025-08-20T02:56:12ZengBMCThrombosis Journal1477-95602025-03-0123111110.1186/s12959-025-00704-0Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort studyYayun Xu0Haixing Feng1Zhengzheng Huang2Yanlei Li3Feng Chi4Lijie Ren5Department of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityDepartment of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityDepartment of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityDepartment of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityDepartment of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityDepartment of Neurology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen UniversityAbstract Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is the preferred treatment for acute ischemic stroke (AIS). Nevertheless, only approximately half of patients undergoing IVT experience positive outcomes. The objective of the study was to examine the clinical characteristics of patients with AIS and identify predictors for unfavorable clinical outcomes at 3 months after IVT. This retrospective cohort study comprised 3805 consecutive patients diagnosed with AIS who received IVT. Patients categorized as having a poor outcome were those with a modified Rankin scale score (mRS) of 3–6, while those categorized as having a good outcome had a score of 0–2. Clinical profiles and laboratory examinations were compared among patients with differing outcomes. A logistic regression model was utilized to investigate potential factors correlated with unfavorable outcomes. Of the 3805 patients included in the study, 3176 (83.5%) were found to have a good outcome, while 629 (16.5%) experienced an poor outcome following IVT. Advancing age (OR = 1.037, P < 0.001) and higher baseline National Institutes of Health Stroke Scale (NIHSS) scores (OR = 1.156, P < 0.001) were significant independent predictors of a poor outcome. The area under curve (AUC) values for age, NIHSS score, and the combined effect of age and NIHSS score in predicting a poor response were 0.644, 0.761, and 0.777, respectively. Our research indicates that advancing age and higher baseline NIHSS score may serve as prognostic indicators for predicting early unfavorable outcomes following IVT in patients with AIS.https://doi.org/10.1186/s12959-025-00704-0Acute ischemic strokeIntravenous thrombolysisAgeBaseline NIHSS scoreResponse
spellingShingle Yayun Xu
Haixing Feng
Zhengzheng Huang
Yanlei Li
Feng Chi
Lijie Ren
Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
Thrombosis Journal
Acute ischemic stroke
Intravenous thrombolysis
Age
Baseline NIHSS score
Response
title Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
title_full Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
title_fullStr Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
title_full_unstemmed Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
title_short Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study
title_sort outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r tpa in patients with acute ischemic stroke a retrospective cohort study
topic Acute ischemic stroke
Intravenous thrombolysis
Age
Baseline NIHSS score
Response
url https://doi.org/10.1186/s12959-025-00704-0
work_keys_str_mv AT yayunxu outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy
AT haixingfeng outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy
AT zhengzhenghuang outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy
AT yanleili outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy
AT fengchi outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy
AT lijieren outcomesandriskfactorsforfunctionalprognosisat3monthsafterintravenousthrombolysiswithrtpainpatientswithacuteischemicstrokearetrospectivecohortstudy